Literature DB >> 12711183

The influence of carrier and drug morphology on drug delivery from dry powder formulations.

Hassan Larhrib1, Gary Peter Martin, Christopher Marriott, David Prime.   

Abstract

Lactose was crystallised either from neutralised Carbopol 934 gel or from water-ethanol solution without stirring, with a view to obtaining lactose alpha-monohydrate of favourable shape and smooth surface, suitable for use as carriers in formulations for dry powder inhalers (DPIs). Crystallisation of salbutamol sulphate was carried out in the presence of water, lecithin and ethanol to form salbutamol crystals with defined shape and smooth surface. The crystals formed were needle-shaped, with a length of less than 6 microm and a width between 0.5 and 1 microm. DSC and TGA showed that lactose crystals produced from Carbopol gel or from water-ethanol solution existed as alpha-lactose monohydrate. The DSC thermograms of micronised and crystallised salbutamol sulphate showed two similar endothermic transitions at 200 and 290 degrees C, respectively. The first transition was initially thought to correspond to the melting of salbutamol sulphate. However, the shape of the particles as observed by optical microscopy was not altered after heating the sample to 250 degrees C, suggesting that no transition from solid to liquid state occurred at 200 degrees C. This was confirmed by observations made using hot stage microscopy. The two endothermic transitions are suggested to correspond to the decomposition of the salbutamol sulphate molecule. The elongation ratio of the commercial lactose crystals, lactose crystallised from Carbopol and from water-ethanol were 1.69+/-0.05, 2.01+/-0.13 and 6.25+/-0.17, respectively. As the elongation ratio increased the flow properties of the carrier were affected detrimentally and this consequently reduced the content uniformity of salbutamol sulphate and drug emission from the inhaler device. Whereas, increasing the elongation ratio of the carrier or drug improved the deposition profiles of salbutamol sulphate, suggesting that the more elongated particles would be more aerodynamic and favour deep lung penetration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711183     DOI: 10.1016/s0378-5173(03)00156-x

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  18 in total

1.  New respirable and fast dissolving itraconazole dry powder composition for the treatment of invasive pulmonary aspergillosis.

Authors:  Christophe Duret; Nathalie Wauthoz; Thami Sebti; Francis Vanderbist; Karim Amighi
Journal:  Pharm Res       Date:  2012-05-30       Impact factor: 4.200

2.  Isoxyl aerosols for tuberculosis treatment: preparation and characterization of particles.

Authors:  Chenchen Wang; Anthony J Hickey
Journal:  AAPS PharmSciTech       Date:  2010-03-26       Impact factor: 3.246

Review 3.  Particle engineering for pulmonary drug delivery.

Authors:  Albert H L Chow; Henry H Y Tong; Pratibhash Chattopadhyay; Boris Y Shekunov
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

4.  Inhalable sustained-release formulation of glucagon: in vitro amyloidogenic and inhalation properties, and in vivo absorption and bioactivity.

Authors:  Satomi Onoue; Kazuki Kuriyama; Atsushi Uchida; Takahiro Mizumoto; Shizuo Yamada
Journal:  Pharm Res       Date:  2011-02-02       Impact factor: 4.200

5.  Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study.

Authors:  Sonali R Naikwade; Amrita N Bajaj; Prashant Gurav; Madhumanjiri M Gatne; Pritam Singh Soni
Journal:  AAPS PharmSciTech       Date:  2009-08-01       Impact factor: 3.246

6.  Inhalable lactose-based dry powder formulations of low molecular weight heparin.

Authors:  Shuhua Bai; Vivek Gupta; Fakhrul Ahsan
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-04       Impact factor: 2.849

7.  Effect of particle shape on dry particle inhalation: study of flowability, aerosolization, and deposition properties.

Authors:  Meer Saiful Hassan; Raymond Wai Man Lau
Journal:  AAPS PharmSciTech       Date:  2009-10-29       Impact factor: 3.246

8.  Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy.

Authors:  Eleonora Maretti; Luca Costantino; Francesca Buttini; Cecilia Rustichelli; Eliana Leo; Eleonora Truzzi; Valentina Iannuccelli
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

9.  Effective modification of particle surface properties using ultrasonic water mist.

Authors:  Natalja Genina; Heikki Räikkönen; Jyrki Heinämäki; Osmo Antikainen; Simo Siiriä; Peep Veski; Jouko Yliruusi
Journal:  AAPS PharmSciTech       Date:  2009-03-14       Impact factor: 3.246

10.  Investigations on the humidity-induced transformations of salbutamol sulphate particles coated with L-leucine.

Authors:  Janne Raula; Frank Thielmann; Jarno Kansikas; Sami Hietala; Minna Annala; Jukka Seppälä; Anna Lähde; Esko I Kauppinen
Journal:  Pharm Res       Date:  2008-06-27       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.